CAV1 and type 2 diabetes mellitus: Taken together, our results suggest that ALS-T2DM serum treatment destroys islet cells by excessively increasing CaV1 channel-mediated Ca2+ influx and [Ca2+]i and then pathologically translating the exaggerated [Ca2+]i to eventual mitochondrial dysfunction.